In this project, we demonstrated that GEFT expression was markedly up-regulated in CRC tumor tissues compared to adjacent normal tissues, which was in line with our prior immunohistochemistry analysis (11). This evidence concerns the gene ARHGEF25 and colorectal carcinoma.